Canaccord


Canaccord Top Analyst Nearly Doubles Price Target on InvenSense Inc (INVN) and Shares Rise 18% Following M&A Agreement with TKD Corporation

InvenSense Inc (NYSE:INVN) shares took flight today, accelerating 18% after news broke that the company is to be acquired by TKD Corporation for $13 …

Canaccord Cautious on Nike Inc (NKE) Following Underwhelming Q2 Future Sales

Canaccord analyst Camilo Lyon is advising a caution light when it comes to investing in shares of Nike Inc (NYSE:NKE) after the athletic …

Canaccord Assumes a Buy on KemPharm Inc (KMPH); Sees 154% Upside for the Stock

Dewey Steadman of research firm Canaccord is chiming in today on shares of KemPharm Inc (NASDAQ:KMPH) from a confident perspective. The analyst assumed …

Canaccord Chimes in on Radius Health Inc (RDUS) Following Promising Phase 1 Data in Breast Cancer

Yesterday, Radius Health Inc (NASDAQ:RDUS) shares rose a solid 6% on back of RAD-1901 Phase 1 study clinical data that proved to be better …

Canaccord Lays Out the Bullish Case for Agios Pharmaceuticals Inc (AGIO) Despite IND Withdrawal

Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares were thundering down 19% yesterday after news came to light that the firm has withdrawn its Investigational New …

Top Analysts Recommend Chip Giants Advanced Micro Devices, Inc. (AMD) and Skyworks Solutions Inc (SWKS) Amid Stock Volatility and Slower iPhone Sales

Two of the best-performing analysts on Wall Street are positive on chip giants Advanced Micro Devices, Inc. (NASDAQ:AMD) and Skyworks Solutions Inc (NASDAQ:SWKS).

Canaccord Weighs in on Valeant Pharmaceuticals Intl Inc (VRX) Amid Regime Turnover of High-Level Executives

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares were falling 5% yesterday after the reveal that three high-level executives were on their way out of …

Canaccord Comments on Synergy Pharmaceuticals Inc (SGYP) Following First Phase 3 Data in IBS-C

In a research report released Friday, Canaccord analyst John Newman reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with a $13 price …

Canaccord Chimes In On Pandora Media Inc (P) Amid Premium Feature Unveiling

Yesterday evening at live event, Pandora Media Inc (NYSE:P) unveiled its Premium feature for $9.99 per month as an accessible offering to its …

Canaccord Continues to Be Sidelined on Twitter Inc (TWTR) Following Proprietary Sampling Results

After refreshing his proprietary sampling of Twitter Inc (NYSE:TWTR) accounts to evaluate how engagement and monthly active users (MAUs) are tracking this quarter, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts